MENLO PARK, Calif. (AP) _ Dermira Inc. (DERM) on Tuesday reported a loss of $57.6 million in its third quarter.
On a per-share basis, the Menlo Park, California-based company said it had a loss of $1.06.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.40 per share.
The skin condition drug developer posted revenue of $11.5 million in the period, which also beat Street forecasts. Three analysts surveyed by Zacks expected $11.1 million.
Dermira shares have dropped roughly 6% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $6.77, a decrease of 43% in the last 12 months.